BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 30898756)

  • 1. Neutrophil/Lymphocyte Ratio Is an Independent Prognostic Factor in Elderly Patients with High-Grade Gliomas.
    Gan Y; Zhou X; Niu X; Li J; Wang T; Zhang H; Yang Y; Liu Y; Mao Q
    World Neurosurg; 2019 Jul; 127():e261-e267. PubMed ID: 30898756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Cumulative Score Based on Preoperative Neutrophil-Lymphocyte Ratio and Fibrinogen in Predicting Overall Survival of Patients with Glioblastoma Multiforme.
    Hao Y; Li X; Chen H; Huo H; Liu Z; Tian F; Chai E
    World Neurosurg; 2019 Aug; 128():e427-e433. PubMed ID: 31042598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative neutrophil-lymphocyte ratio correlated with glioma grading and glioblastoma survival.
    Weng W; Chen X; Gong S; Guo L; Zhang X
    Neurol Res; 2018 Nov; 40(11):917-922. PubMed ID: 30074469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Neutrophil/Lymphocyte Ratio Is an Independent Prognostic Biomarker in Patients with Low-Grade Gliomas.
    Tan Z; Shen L; Wu H; Deng L; Li Z; Huang X
    World Neurosurg; 2019 Dec; 132():e585-e590. PubMed ID: 31442642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Value of the Pretreatment Neutrophil/Lymphocyte Ratio in Patients with Glioblastoma Multiforme Brain Tumors: A Retrospective Cohort Study of Patients Treated with Combined Modality Surgery, Radiation Therapy, and Temozolomide Chemotherapy.
    Brenner A; Friger M; Geffen DB; Kaisman-Elbaz T; Lavrenkov K
    Oncology; 2019; 97(5):255-263. PubMed ID: 31288238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of inflammation markers in postoperative gliomas with or without adjuvant treatments.
    Luo Y; Deng R; Zhong Q; Luo D; Li X; Chen X; Tao S; Feng Z; Jiayi L; Huang Y; Li J; Liu W
    Medicine (Baltimore); 2021 Jun; 100(25):e26437. PubMed ID: 34160435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment neutrophil-to-lymphocyte/monocyte-to-lymphocyte ratio as prognostic biomarkers in glioma patients.
    Chim ST; Sanfilippo P; O'Brien TJ; Drummond KJ; Monif M
    J Neuroimmunol; 2021 Dec; 361():577754. PubMed ID: 34700046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of neutrophil-to-lymphocyte ratio in gliomas: a systematic review and meta-analysis.
    Lei YY; Li YT; Hu QL; Wang J; Sui AX
    World J Surg Oncol; 2019 Aug; 17(1):152. PubMed ID: 31472673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of worse survival after resection in patients with brain metastasis.
    Mitsuya K; Nakasu Y; Kurakane T; Hayashi N; Harada H; Nozaki K
    J Neurosurg; 2017 Aug; 127(2):433-437. PubMed ID: 27911233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
    Fujii Y; Muragaki Y; Maruyama T; Nitta M; Saito T; Ikuta S; Iseki H; Hongo K; Kawamata T
    J Neurosurg; 2018 Jul; 129(1):1-9. PubMed ID: 28885120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative Hematologic Inflammatory Markers as Prognostic Factors in Patients with Glioma.
    Bao Y; Yang M; Jin C; Hou S; Shi B; Shi J; Lin N
    World Neurosurg; 2018 Nov; 119():e710-e716. PubMed ID: 30092479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival.
    Mason M; Maurice C; McNamara MG; Tieu MT; Lwin Z; Millar BA; Menard C; Laperriere N; Milosevic M; Atenafu EG; Mason W; Chung C
    J Neurooncol; 2017 May; 132(3):463-471. PubMed ID: 28332000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corpus callosum involvement and postoperative outcomes of patients with gliomas.
    Chen KT; Wu TW; Chuang CC; Hsu YH; Hsu PW; Huang YC; Lin TK; Chang CN; Lee ST; Wu CT; Tseng CK; Wang CC; Pai PC; Wei KC; Chen PY
    J Neurooncol; 2015 Sep; 124(2):207-14. PubMed ID: 26033546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Prognosis of Neuroglioma Based on Dynamic Magnetic Resonance Enhancement.
    Li F; Zhang Y; Wang N; Song C; Gao Y; Diao X; Zhang H
    World Neurosurg; 2020 Jun; 138():663-671. PubMed ID: 31981784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with glioma.
    Wang J; Xiao W; Chen W; Hu Y
    EXCLI J; 2018; 17():505-512. PubMed ID: 30034313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Survival of newly diagnosed malignant glioma patients on combined modality therapy].
    Yang QY; Shen D; Sai K; Jiang XB; Ke C; Zhang XH; Mou YG; Chen ZP
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(1):8-10. PubMed ID: 23578444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgically Resectable Pancreatic Neuroendocrine Tumors.
    Zhou B; Zhan C; Wu J; Liu J; Zhou J; Zheng S
    Med Sci Monit; 2017 Nov; 23():5574-5588. PubMed ID: 29168979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
    Wu F; Wu LL; Zhu LX
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
    [No Abstract]   [Full Text] [Related]  

  • 19. Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study.
    Woo PYM; Ho JMK; Tse TPK; Lam SW; Mak CHK; Chan DTM; Lee MWY; Wong ST; Chan KY; Poon WS
    J Clin Neurosci; 2019 May; 63():134-141. PubMed ID: 30712777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution.
    Yang P; Wang Y; Peng X; You G; Zhang W; Yan W; Bao Z; Wang Y; Qiu X; Jiang T
    J Neurooncol; 2013 Jun; 113(2):259-66. PubMed ID: 23483435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.